ANRO
Alto Neuroscience, Inc.Company with tickers: ANRO
CIK
1999480
CUSIP
02157Q109
Shares Outstanding
35,093,940
13F Activity (30d)
105 filings
105 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $27,138,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $20,294,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-27,138,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-26,237,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.80 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.80 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |